HESHE ED Pack: Comprehensive Treatment for Erectile Dysfunction
| Product dosage: 6000mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.67
Best per pill | $100.46 (0%) | 🛒 Add to cart |
The HESHE ED Pack offers a clinically-formulated, multi-agent approach to managing erectile dysfunction (ED), combining established phosphodiesterase type 5 (PDE5) inhibitors to address varying patient needs and response profiles. Developed for individuals who have experienced suboptimal results with monotherapy, this pack provides flexibility, enhanced efficacy, and personalized dosing options under medical supervision. It is designed for adult males diagnosed with organic, psychogenic, or mixed-etiology ED, following thorough cardiovascular assessment and exclusion of contraindications. Each component medication has been rigorously tested and is approved for this indication, ensuring reliability and predictable pharmacokinetics.
Features
- Contains a combination of Sildenafil, Tadalafil, and Vardenafil in therapeutic doses
- Tailored dosing options: includes both short-acting and long-acting PDE5 inhibitors
- Manufactured in FDA-approved facilities following cGMP standards
- Blister-packed for stability, portability, and discreet use
- Includes detailed patient information leaflet and dosage guide
- Available only with a valid prescription from a licensed healthcare provider
Benefits
- Enables individualized therapy based on duration of effect desired and personal response
- Increases likelihood of treatment success through multiple mechanism options
- Redensensitization potential in cases of prior monotherapy non-response
- Improves sexual confidence and relationship satisfaction
- Offers convenience with pre-packaged, organized dosing units
- Provides cost-effectiveness compared to purchasing each medication separately
Common use
The HESHE ED Pack is prescribed for the treatment of erectile dysfunction in adult males. It is suitable for patients who may benefit from a trial of different PDE5 inhibitors due to variable individual responses, side effect profiles, or timing preferences. It is commonly used when a patient has not achieved satisfactory results with a single agent or wishes to evaluate multiple options under medical guidance. The pack is intended for use in anticipation of sexual activity and is not designed for continuous daily dosing unless specifically directed by a physician based on the included agents.
Dosage and direction
Dosage must be individualized under medical supervision. A typical pack may include:
- Sildenafil 50mg or 100mg tablets: take approximately 30-60 minutes before anticipated sexual activity
- Tadalafil 10mg or 20mg tablets: take at least 30 minutes before sexual activity; effects may last up to 36 hours
- Vardenafil 10mg tablets: take approximately 25-60 minutes before sexual activity
Do not exceed one dose of any single medication within a 24-hour period. The pack is designed for sequential trial under physician guidance to determine optimal therapy. Take with a glass of water; may be taken with or without food, though high-fat meals may delay onset of action for some components. Do not crush, chew, or break tablets.
Precautions
- Prior to use, undergo comprehensive medical evaluation to assess cardiovascular health
- Not recommended for use with other ED treatments or recreational erectile aids
- Use caution in patients with anatomical penile deformity, Peyronie’s disease, or conditions that may predispose to priapism
- May cause dizziness or visual changes; avoid activities requiring alertness until effects are known
- Use cautiously in patients with bleeding disorders or active peptic ulcer disease
- Not intended for use by women or children
- Protect from moisture and excessive heat
Contraindications
- Concomitant use of organic nitrates in any form (including amyl nitrite “poppers”)
- History of hypersensitivity to any PDE5 inhibitor or component of the formulation
- Patients with severe hepatic impairment (Child-Pugh class C)
- End-stage renal disease requiring dialysis
- Unstable angina, recent myocardial infarction, or life-threatening arrhythmias
- History of non-arteritic anterior ischemic optic neuropathy (NAION)
- Retinitis pigmentosa or other hereditary retinal disorders
- Concomitant use with guanylate cyclase stimulators such as riociguat
Possible side effects
Common side effects (≥1/100 to <1/10):
- Headache
- Flushing
- Dyspepsia
- Nasal congestion
- Back pain or myalgia (more common with tadalafil)
- Visual disturbances (color tinge, blurred vision)
Uncommon side effects (≥1/1,000 to <1/100):
- Dizziness
- Hypotension
- Palpitations
- Gastroesophageal reflux
Rare but serious side effects (<1/1,000):
- Priapism (prolonged erection >4 hours)
- Sudden hearing loss
- Severe cardiovascular events
- Seizures
- Allergic reactions including anaphylaxis
Drug interaction
- Absolute contraindication: nitrates (isosorbide mononitrate, dinitrate, nitroglycerin)
- Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir): dose reduction recommended
- Alpha-blockers (doxazosin, terazosin): increased risk of hypotension
- Antihypertensives: additive blood pressure lowering effects
- Grapefruit juice: may increase plasma concentrations
- Other PDE5 inhibitors: avoid concomitant use
- Alcohol: may increase risk of hypotension and orthostatic symptoms
Missed dose
The HESHE ED Pack is used on an as-needed basis rather than a scheduled regimen. If a dose is missed or not used within the anticipated timeframe, simply resume with the next planned dose before sexual activity. Do not take extra tablets to make up for missed timing. The medications are designed for single use prior to sexual activity and do not require regular dosing schedules.
Overdose
In case of suspected overdose, seek immediate medical attention. Symptoms may include severe headache, profound hypotension, syncope, prolonged erection, and cardiovascular events. Supportive measures should be implemented, including supine positioning with legs elevated if hypotensive. Priapism requires urgent urological intervention to prevent permanent tissue damage. Dialysis is not expected to significantly enhance elimination due to high protein binding.
Storage
Store at room temperature (15-30°C or 59-86°F) in the original packaging. Protect from light and moisture. Keep blister strips sealed until use. Do not transfer tablets to other containers. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Properly dispose of unused medications through drug take-back programs.
Disclaimer
This product requires a prescription and should be used only under the supervision of a qualified healthcare provider. The information provided here is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Individual results may vary. Not all users will experience the same benefits or side effects. Always consult with a healthcare provider before starting any new medication regimen.
Reviews
“After struggling with inconsistent results from single-agent therapy, the HESHE ED Pack allowed my physician and me to systematically identify the most effective option for my specific needs. The variety provided flexibility for different situations.” - Mark T., 52
“As a cardiologist, I appreciate the structured approach this pack offers for titration and agent selection. It facilitates informed decision-making while maintaining safety parameters.” - Dr. Evans, MD
“The convenience of having multiple options in one package eliminated the need for separate prescriptions during the trial period. The educational materials were comprehensive and helpful.” - James L., 48